Cytisinicline for smoking cessation in individuals with self-reported COPD: a post hoc analysis of the ORCA-2 and ORCA-3 trials

Journal:

Thorax

Published:

2025-09-17

DOI:

10.1136/thorax-2025-223880

Affiliations:

3

Authors:

5

Go to article

Institutions	Authors	Share
Achieve Life Sciences, Inc., United States of America (USA)	3.000000	0.60
Stanford University School of Medicine, United States of America (USA)	1.000000	0.20
Trial Architecture Consulting (TriArc), United States of America (USA)	1.000000	0.20

Interested in Public Health?